Thursday, August 18, 2022
- Advertisement -spot_img

TAG

Drug Manufacturing

Cassava Sciences Inc. Reports $9.6 Million Net Loss for the 3rd Quarter, 2021.

Cassava Sciences, Inc (Nasdaq: SAVA) published financial results for the third quarter, 2021. The results indicate a net loss of $9.6 million, which is...

Latest news

- Advertisement -spot_img